Ticker Details
Stoke Therapeutics, Inc.
IPO Date:	June 17, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.71 | 3.54%
Avg Daily Range (30 D):	$0.83 | 2.72%
Avg Daily Range (90 D):	$0.72 | 2.31%

Institutional Daily Volume
Avg Daily Volume:	.36M
Avg Daily Volume (30 D):	.55M
Avg Daily Volume (90 D):	.52M

Trade Size
Avg Trade Size (Sh.):	73
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	1,711
Avg Institutional Trade:	$2.36M
Avg Institutional Trade (30 D):	$3.41M
Avg Institutional Trade (90 D):	$3.51M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.35M
Avg Closing Trade (30 D):	$3.31M
Avg Closing Trade (90 D):	$4.32M
Avg Closing Volume:	106.21K

News

Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights

May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights

May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research

Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research

Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.37	$-.93	$-.79
Diluted EPS	$-3.34	$-.93	$-.79
Revenue	$27.59M	$9.33M	$6.23M
Gross Profit
Net Income / Loss	$-207.9M	$-61.62M	$-50M
Operating Income / Loss	$-223.38M	$-65.43M	$-53.42M
Cost of Revenue
Net Cash Flow	$11.46M	$-45.66M	$74.44M
PE Ratio

Splits
Jun 06, 2019	10:99